Minimally Invasive Heart Navigator-B (02160.HK): ENO series pacemakers received CE approval for LBBAP indications.

Smart Finance App News, MicroPort Mindray -B (02160.HK) announced that recently, the ENO series of cardiac pacemakers independently developed by the Group has obtained CE approval for left bundle branch area pacing (LBBAP) indications. With this, all six CE-certified pacemakers of the Group have obtained LBBAP indications. Coupled with the commercialized FLEXIGO 3D LBBAP delivery system and VegaTM M58 electrode lead, the Group now has a complete solution for LBBAP therapy, which can meet the clinical needs of more patients and further expand revenue sources.